Welcome to our dedicated page for Azenta news (Ticker: AZTA), a resource for investors and traders seeking the latest updates and insights on Azenta stock.
Azenta Inc (Nasdaq: AZTA) is a global leader in life sciences solutions, providing essential tools for drug development, clinical research, and genomic discovery. This page aggregates official press releases and verified news about the company’s advancements in cold-chain sample management, automated storage systems, and multiomics services.
Investors and researchers will find timely updates on Azenta’s operational milestones, including earnings reports, strategic partnerships, product innovations, and industry recognition. The curated content addresses key areas such as sample integrity technologies, genomic data accuracy, and global service expansions.
Key updates include developments from Azenta’s core segments: Life Sciences Products (automated storage solutions, lab consumables) and Life Sciences Services (genomic sequencing, multiomics analytics). Content is organized to help stakeholders track progress in critical research areas like precision medicine and biotherapeutic development.
Bookmark this page for streamlined access to Azenta’s latest announcements, or check regularly for insights into how the company continues to shape the future of life sciences infrastructure and biomedical innovation.
Azenta, Inc. (Nasdaq: AZTA) has announced a definitive agreement to acquire Barkey Holding GmbH, a leading provider of controlled rate thawing devices for the medical industry, for approximately €80 million. The acquisition is expected to close in early July 2022 and will enhance Azenta's cold chain product offerings in the growing cell and gene therapy market. Barkey generated around €17 million in revenue over the past year and will add significant capabilities to Azenta's operations. The acquisition is anticipated to be accretive to non-GAAP earnings immediately and to GAAP earnings within a year.
Azenta, Inc. (Nasdaq: AZTA) will participate in the Jefferies Healthcare Conference in New York City on June 9, 2022, with a presentation scheduled for 3:30 PM ET. The event will be available via live webcast on Azenta's investor relations website, with a replay accessible afterward.
As a provider of life sciences solutions, Azenta focuses on cold-chain sample management and genomic services, aiding drug development and clinical research. The company rebranded from Brooks Automation, Inc. on December 1, 2021.
Azenta, Inc. (Nasdaq: AZTA), a leading provider of life sciences solutions, will participate in the UBS Global Healthcare Conference on May 24, 2022, at 2:45 pm ET. The live presentation can be accessed via the investor relations website. Azenta, previously known as Brooks Automation, provides essential cold-chain sample management and genomic services, supporting drug development and advanced therapies across various sectors.
Azenta, Inc. (Nasdaq: AZTA) reported preliminary Q2 results for the period ended March 31, 2022. Revenue from continuing operations reached $146 million, reflecting a 12% year-over-year increase. Life Sciences Services showed significant growth of 19%, primarily in Sample Repository Solutions and Genomics Services. However, the company posted a diluted EPS from continuing operations of ($0.02), down from $0.04 the previous quarter, and operating losses totaled $5 million. Azenta anticipates Q3 revenue between $140 million to $150 million.
Azenta, Inc. (Nasdaq: AZTA) has rescheduled its second fiscal quarter earnings release for 2022 from May 3, 2022, to May 9, 2022, due to delays in the quarter-end closing process following the sale of its Semiconductor Automation business on February 1, 2022. The company anticipates that the second quarter revenue and non-GAAP EPS will remain within the previously issued guidance range. A conference call is scheduled for May 9, 2022, at 4:30 p.m. ET to discuss the financial results.
Azenta, Inc. (Nasdaq: AZTA) will announce its fiscal 2022 second quarter earnings on May 3, 2022, after market close. The results will cover the quarter ending March 31, 2022. A conference call to discuss these results is scheduled for 4:30 p.m. Eastern Time on the same day, accessible via phone and live webcast. Azenta specializes in life sciences solutions, offering cold-chain sample management and genomic services to major pharmaceutical and biotech companies worldwide.
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the 21st Annual Needham Virtual Healthcare Conference on April 12, 2022, featuring a presentation at 9:30 am ET. The event will be accessible via a live webcast on the Azenta investor relations website, with a replay available afterward. Azenta provides comprehensive life sciences solutions, focusing on cold-chain sample management and genomic services for pharmaceutical and biotech industries globally. The company rebranded from Brooks Automation to Azenta, Inc. on December 1 last year.
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 22, 2022. The event will feature a presentation at 3:00 PM ET in a virtual format, accessible via Azenta's investor relations website.
Azenta specializes in life sciences solutions, offering cold-chain sample management and genomic services for drug development and clinical research. The company rebranded from Brooks Automation, Inc. on December 1.
Azenta, Inc. (Nasdaq: AZTA) will participate in the Barclays Global Healthcare Conference on March 15, 2022, with a presentation at 10:15am ET. The event takes place in Miami, FL, and a live webcast is available on Azenta's investor relations website. A replay will also be accessible post-event. Azenta specializes in life sciences solutions, offering cold-chain sample management and genomic services. The company rebranded from Brooks Automation on December 1, adopting the new name and ticker symbol.
Azenta, Inc. (Nasdaq: AZTA) will participate in Cowen's 42nd Annual Health Care Conference on March 8, 2022, with a live presentation at 2:10 PM ET. The conference will be held virtually, and interested parties can access the live webcast via the Azenta investor relations website. A replay will be available after the event. Azenta is a global leader in life sciences solutions, providing cold-chain sample management and genomic services to the pharmaceutical and biotech industries.
FAQ
What is the current stock price of Azenta (AZTA)?
What is the market cap of Azenta (AZTA)?
